Efficacy and Safety of a Biosimilar Liraglutide (Melitide(®)) Versus the Reference Liraglutide (Victoza(®)) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial

INTRODUCTION: Liraglutide effectively controls blood glucose level and reduces body weight. The aim of this study was to compare the efficacy and safety of a biosimilar liraglutide (Melitide(®); CinnaGen, Tehran, Iran) to the reference liraglutide (Victoza(®); Novo Nordisk, Bagsvaerd, Denmark) in pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Esteghamati, Alireza, Zamanzadeh, Mehran, Malek, Mojtaba, Khaledi, Mohammad, Monavari, Arezoo, Najafi, Laily, Banazadeh, Zahra, Malboosbaf, Ramin, Aghili, Rokhsareh, Mahdikhah, Sedigheh, Ganjizadeh-Zavereh, Hasan, Kafi, Hamidreza, Hosseinpanah, Farhad, Khamseh, Mohammad Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570258/
https://www.ncbi.nlm.nih.gov/pubmed/37707701
http://dx.doi.org/10.1007/s13300-023-01462-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570258/
https://www.ncbi.nlm.nih.gov/pubmed/37707701
http://dx.doi.org/10.1007/s13300-023-01462-w

Ejemplares similares